Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cartesian Therapeutics (RNAC) Asset Utilization Ratio (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Asset Utilization Ratio for 11 consecutive years, with 0.0 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio fell 103.98% year-over-year to 0.0; the TTM value through Mar 2026 reached 0.0, down 103.98%, while the annual FY2025 figure was 0.0, 98.94% down from the prior year.
  • Asset Utilization Ratio hit 0.0 in Q1 2026 for Cartesian Therapeutics, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.76 in Q2 2022 and bottomed at 0.0 in Q1 2026.
  • Average Asset Utilization Ratio over 5 years is 0.27, with a median of 0.13 recorded in 2023.
  • Year-over-year, Asset Utilization Ratio surged 337.53% in 2022 and then tumbled 103.98% in 2026.
  • Cartesian Therapeutics' Asset Utilization Ratio stood at 0.64 in 2022, then tumbled by 80.35% to 0.13 in 2023, then plummeted by 32.35% to 0.09 in 2024, then crashed by 99.64% to 0.0 in 2025, then crashed by 1131.95% to 0.0 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.0, 0.0, and 0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.